Aug. 31, 2026 — A new heart failure (HF) treatment effect calculator could help overcome one of the largest barriers to effective heart failure care by predicting the expected effects of treatment on ...
ESC
This channel contains news about the European Society of Cardiology (ESC), including coverage of its annual meeting and new guidelines. ESC is a leading resource for cardiology science and information in Europe.
Aug. 31, 2026 — Caristo Diagnostics has announced new independent University of Oxford-led research showing that Caristo ...
Aug. 31, 2026 — Amgen has announced new findings showing Repatha (evolocumab) reduced the risk of death in high-risk ...
Aug. 30, 2026 — Bayer has announced the presentation of first detailed results from the Phase III REVEAL study, an ...
Aug. 31, 2026 — At the European Society of Cardiology Congress in Munich, Abbott announced new late-breaking 12-month ...
Aug. 31, 2026 — A new heart failure (HF) treatment effect calculator could help overcome one of the largest barriers to ...
Aug. 28, 2026 — GE HealthCare has announced three additions to its Vivid cardiovascular ultrasound portfolio — Vivid Exp ...
Aug. 28, 2026 — At ESC Congress in Munich, the European Society of Cardiology released its first updated heart failure ...
Aug. 20, 2026 — Bayer has announced that 11 oral presentations across its cardiovascular, kidney, and secondary stroke ...
July 23, 2026 — The results of 59 ground-breaking trials will be unveiled for the first time at ESC Congress 2026, the ...
July 21, 2026 — Vesalio recently announced that the results from the randomized NATURE clinical trial evaluating the ...
June 23, 2026 — The European Society of Cardiology (ESC) Congress 2026 will take place in Munich Aug. 28–31, 2026. ESC ...
June 19, 2026 — The cardioprotective effects of heart failure treatments in patients with cancer were demonstrated in a ...
May 26, 2026 — According to researchers in Europe, women are more likely to face delays in diagnosis of cardiovascular ...
May 10, 2026 — Results from the first randomized trial evaluating microRNA inhibition in heart failure were presented ...
April 14, 2026 — Implicity, a provider of remote patient monitoring and cardiac data management solutions, recently ...
September 04, 2026